SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responsesWanwisa Dejnirattisai, Malcolm G. Semple, Suman Khan et al.|Cell|2022Cited by 1k
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serumChang Liu, Mark A. Williams, Helen M. Ginn et al.|Cell|2021Cited by 749
Antibody evasion by the P.1 strain of SARS-CoV-2Wanwisa Dejnirattisai, Gavin Screaton, Daming Zhou et al.|Cell|2021Cited by 661
Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virusChristian Happi, Túlio de Oliveira, Ifedayo Adetifa et al.|PLoS Biology|2022Cited by 350
SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourseFrank Konings, Maria D. Van Kerkhove, Mark D. Perkins et al.|Nature Microbiology|2021Cited by 315